- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gerresheimer AG (GXIG)
Gerresheimer AG stock price live, this page displays ETR GXIG stock exchange data. View the GXIG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Gerresheimer AG real time stock price chart below.
What Is the Gerresheimer AG Stock Price Today?
The Gerresheimer AG stock price today is 26.590.
What Is the Stock Symbol for Gerresheimer AG?
The stock symbol for Gerresheimer AG is "GXIG."
What Stock Exchange Does Gerresheimer AG Trade On?
Gerresheimer AG is listed and trades on the Xetra stock exchange.
Is Gerresheimer AG a Good Stock to Buy?
Determining whether Gerresheimer AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GXIG quote. (ISIN: DE000A0LD6E6)
What Is the Gerresheimer AG Stock Price Today?
The Gerresheimer AG stock price today is 26.590.
What Is the Stock Symbol for Gerresheimer AG?
The stock symbol for Gerresheimer AG is "GXIG."
What Stock Exchange Does Gerresheimer AG Trade On?
Gerresheimer AG is listed and trades on the Xetra stock exchange.
Is Gerresheimer AG a Good Stock to Buy?
Determining whether Gerresheimer AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GXIG quote. (ISIN: DE000A0LD6E6)
26.590
-1.670(-5.91%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.420
28.060
52 wk Range
14.830
47.400
GXIG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.42028.060
52 wk Range
14.83047.400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GXIG Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
24.445
Downside
-8.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
6 Hold
4 Sell
Ratings:
12 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 24.445
(-8.07% Downside)
Gerresheimer AG Earnings Call Summary for Q4/2025
- Gerresheimer reported €2.3B revenue (+€330M YoY) but only 0.3% organic growth, with adjusted EBITDA flat at €384M and negative €86M free cash flow.
- Shares fell 3.47% to $25.06 as investors focused on weak cash generation, high 4.95x debt leverage, and €1.65 EPS loss despite completing compliance cleanup.
- Primary Packaging Glass segment remained under pressure from lower volumes and plant issues; syringes/medical devices grew on GLP-1 demand and new project ramps.
- Management expects 2026 revenue at lower half of €2.3-2.4B range, EBITDA margin of 17-18%, but negative €50-100M free cash flow excluding Centor sale proceeds.
- CEO prioritized selling Centor by November 2026 and completing debt refinancing with Lazard; transformation program expected to add €10-20M EBITDA in 2026.
Last Updated: 2026-06-29, 10:08 a/m
Read Full TranscriptEarnings
Latest Release
Jun 29, 2026
EPS / Forecast
-0.06 / 0.98
Revenue / Forecast
639.5M / 623.89M
Compare GXIG to Peers and Sector
Metrics to compare | GXIG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGXIGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.9x | 17.6x | −0.4x | |
PEG Ratio | 0.01 | 0.12 | 0.00 | |
Price/Book | 0.9x | 1.7x | 2.6x | |
Price / LTM Sales | 0.4x | 1.2x | 2.9x | |
Upside (Analyst Target) | −21.3% | 16.3% | 56.8% | |
Fair Value Upside | Unlock | 7.3% | 8.9% | Unlock |
Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Gerresheimer AG (GXIG) Stock Price Today?
The Gerresheimer AG stock price today is 26.590 EUR.
What Stock Exchange Does Gerresheimer AG Trade On?
Gerresheimer AG is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for Gerresheimer AG?
The stock symbol for Gerresheimer AG is "GXIG."
What Is the Gerresheimer AG Market Cap?
As of today, Gerresheimer AG market cap is 960.560M EUR.
What Is Gerresheimer AG's Earnings Per Share (TTM)?
The Gerresheimer AG EPS (TTM) is -9.274.
When Is the Next Gerresheimer AG Earnings Date?
Gerresheimer AG will release its next earnings report on Jul 30, 2026.
From a Technical Analysis Perspective, Is GXIG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Gerresheimer AG Stock Split?
Gerresheimer AG has split 0 times.
How Many Employees Does Gerresheimer AG Have?
Gerresheimer AG has 13528 employees.
What is the current trading status of Gerresheimer AG (GXIG)?
As of Jul 28, 2026, Gerresheimer AG (GXIG) is trading at a price of 26.590 EUR, with a previous close of 28.260 EUR. The stock has fluctuated within a day range of 26.420 EUR to 28.060 EUR, while its 52-week range spans from 14.830 EUR to 47.400 EUR.
What Is Gerresheimer AG (GXIG) Price Target According to Analysts?
The average 12-month price target for Gerresheimer AG is 24.445 EUR, with a high estimate of 46 EUR and a low estimate of 12.5 EUR. 2 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an -8.07% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.